ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1193

Diagnostic value of Contrast-Enhanced MR-Angiography in diagnosing large Vessel Vasculitis

Sabine Adler1, Marco Sprecher1, Harald Bonel2, Thorsten Klink2 and Peter M. Villiger3, 1Rheumatology, Immunology, Allergology, University Hospital Bern, Bern, Switzerland, 2Diagnostic, Interventional and Pediatric Radiology, University Hospital Bern, Bern, Switzerland, 3Rheumatology, Immunology and Allergology, University Hospital Bern, Bern, Switzerland

Meeting: 2014 ACR/ARHP Annual Meeting

Keywords: Clinical, diagnostic imaging and large vessel vasculitis, MRI

  • Tweet
  • Email
  • Print
Session Information

Title: Imaging of Rheumatic Diseases: Magnetic Resonance Imaging (MRI)

Session Type: Abstract Submissions (ACR)

Background/Purpose

Diagnosis of large-vessel vasculitis (LVV) remains difficult despite clinical and serological signs and symptoms. Detection by histology might be unavailable in exclusive thoracic or abdominal involvement. PET-scans rarely are ready to be used in every-day practice and CT-scans might miss vascular affections. The value of easily accessible, contrast-enhanced MR-angiographies has only rarely been described.

Methods

Between 2005 and 2012 we investigated 76 patients (44 females, 32 males, aged 18-82 years, mean age 64.5 years) with clinical and serological suspicion of LVV by contrast-enhanced MR-angiography (MRA). Gadolinium was used as contrast-medium. Twenty-nine patients underwent both thoracic and abdominal MRA, 32 patients had thoracic and 15 patients abdominal MRA only. Additional histologies of the temporal arteries were performed in 22 patients. MRAs were independently reviewed by two radiologists. Correlations were measured for clinical, serological, histological and radiological parameters.

Results

LVV was diagnosed by MRA in 20/76 patients with 13/20 being abdominal and 7/20 thoracical vasculitides. Out of those, nine patients showed both thoracical and abominal LVV. Interobserver agreement regarding LVV correlated in all but one patient. Diagnoses other than LVV were fibrosis in 36/76 patients, vascular stenosis in 2/76 and arterial dissection in another 2/76 patients. The remaining 10/76 patients showed no vascular abnormalities. In 7/22 biopsied patients, histology was positive for temporal arteritis; 2 out of those 7 patients had additional LVV. Neither erythrocyte sedimentation rate (ESR) nor C-reactive protein (CRP) showed significant differences regarding patients with or without LVV.

Conclusion

Occult LVV can be detected by MRA despite negative serological and/or histological parameters. MRA enables distinguished diagnosis and therefore initiation of tailored immunosuppression in LVV and allows for follow-up investigations in order to control therapeutic success.


Disclosure:

S. Adler,
None;

M. Sprecher,
None;

H. Bonel,
None;

T. Klink,
None;

P. M. Villiger,
None.

  • Tweet
  • Email
  • Print

« Back to 2014 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/diagnostic-value-of-contrast-enhanced-mr-angiography-in-diagnosing-large-vessel-vasculitis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology